Endo Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results

Friday, July 30, 2010 Drug News
Email Print This Page Comment
Font : A-A+

Endo Pharmaceuticals Holdings Inc.

Condensed Consolidated Cash Flow Data (unaudited)

(in thousands)

Six Months EndedJune 30,

2010

2009

Net cash provided by operating activities

$  176,356

$  140,572

Net cash provided by (used in) investing activities

154,785

(424,758)

Net cash (used in) provided by financing activities

(47,332)

3,482

Net increase (decrease) in cash and cash equivalents

$  283,809

$  (280,704)

Cash and cash equivalents, beginning of period

$  708,462

$  775,693

Cash and cash equivalents, end of period

$  992,271

$  494,989



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook